Head-to-head · Cost-Efficiency Index
Neuvé Health vs MadeMed
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Neuvé Health
Readers who want the route and the base chosen explicitly and will ask what the monthly figure covers before enrolling.
Visit Neuvé HealthMadeMed
Shoppers comfortable paying three months at a time who want one flat price at every dose, or a no-needle sublingual semaglutide tablet.
Visit MadeMedThe verdict
Neuvé Health and MadeMed tie on the Cost-Efficiency Index at 68/100, so neither wins outright on the numbers, so choose on fit. Neuvé Health: Readers who want the route and the base chosen explicitly and will ask what the monthly figure covers before enrolling. MadeMed: Shoppers comfortable paying three months at a time who want one flat price at every dose, or a no-needle sublingual semaglutide tablet.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Neuvé Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Neuvé Health | MadeMed |
|---|---|---|
| Cost-Efficiency Index | 68/100 | 68/100 |
| Semaglutide / mo | $217/monthStandard injectable with B12; the site gives three different answers on whether the medication is inside the figure | $239/moQuarterly plan, billed $717 every 3 months, same price at every dose, compounded |
| Tirzepatide / mo | $324/monthStandard injectable with B12; same unresolved question about what the figure covers | $399/moQuarterly plan, billed $1,197 every 3 months, same price at every dose, compounded |
| Semaglutide / yr (modeled) | $2,604 | $2,868 |
| Tirzepatide / yr (modeled) | $3,888 | $4,788 |
| Coverage | All 50 states | 23 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #158 | #161 |
Neuvé Health
68/100Where the value is
- Prices twelve distinct GLP-1 products before any account: injectable and sublingual, standard and low dose, with a B12 or a B12-free glycine base for each
- States the 503A and 503B compounding classes on the homepage and the About page, which the August record did not find
- Names its founder as a nurse practitioner with a care role rather than referring only to an anonymous network
The tradeoffs
- Three surfaces disagree on whether the medication is inside the monthly price: the weight-loss page is headed "All-in monthly pricing" and lists the compounded drug as included, while its own fine print and the financial policy say medication, labs and supplies are billed separately
- The clinical partner that would settle that question — and that bills for the medication, the labs and the consultation — is never named
MadeMed
68/100Where the value is
- One flat price at every dose, printed dose by dose on each product page
- Offers sublingual semaglutide tablets ($219 a month quarterly) and oral tirzepatide alongside the injections
- You can cancel or pause in one click from your dashboard, and it emails you 7 days before every charge
The tradeoffs
- There is no monthly plan; the shortest commitment is three months, billed up front
- Injectable semaglutide is offered in only 23 states, fewer than the 40 the service lists overall, so check your state on the product page
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.